SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as cannabis stocks surge amid reports that Trump may ease federal restrictions, sparking excitement among retail investors who anticipate a potential short squeeze. Community discussions revolve around the possibility of federal reclassification and its impact on the broader cannabis sector, with some emphasizing the potential for policy shifts to drive stock performance. Despite some skepticism, many anticipate significant gains if regulatory changes materialize.

Jiuzi Holdings, Inc. engages in franchise and operation of retail stores. The firm sells new energy vehicles (NEVs) under the brand name Jiuzi. It operates through the NEVs Sales and Franchise Services segments. The company was founded on October 10, 2019 and is headquartered in Hangzhou, China.

Jiuzi Holdings Inc

Jiuzi Holdings ($JZXN) is trending due to news of securing a commitment to expand its private placement to $1 billion, sparking excitement among traders. The community is drawing comparisons to other China-based runners like $SMX and $TGL, hoping for similar gains. However, concerns about potential dilution and Schwab blocking online trading are also being discussed.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending due to an initial positive reaction to earnings that quickly soured, with the stock dropping in after-hours trading. Despite a strong AI backlog and raised price targets from analysts, concerns over tighter AI margins and lack of clear 2026 guidance are fueling community discussion. Some investors believe this is a buying opportunity, while others fear a broader tech sector rotation.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst is trending following FDA approval of ORLADEYO oral pellets for young children with hereditary angioedema (HAE), making it the first and only targeted oral prophylactic therapy for HAE patients aged 2 and older. Community discussions revolve around the potential for a massive rally and significant short covering, although some traders express concern over share price movement despite positive news. The focus remains on BioCryst's long-term value and the impact of this approval on future sales.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies behind its mission to build a culture-focused cryptocurrency on the Solana blockchain, drawing parallels to Bitcoin. Discussions revolve around Weedcoin's potential within the evolving cannabis industry and its community-driven approach. Some users highlight hemp's phytoremediation properties, while others focus on culture and community.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amid discussions about potential partnerships and its underlying technology, with community members weighing its strengths against other blockchains. Some traders are closely watching for breakout opportunities, while others express frustration with recent price action. The community is also actively discussing meme coins built on Solana, such as $WEEDCOIN and $PMV.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to new highs, fueled by supply constraints and increasing industrial demand for use in green technologies like solar panels and EVs. Community discussions highlight bullish sentiment, particularly around a potential short squeeze and the metal's safe-haven appeal amid economic uncertainty. Some investors are expressing caution regarding overbought conditions and potential pullbacks.

Katapult Holdings, Inc. is an e-commerce focused financial technology company. The firm is engaged in the provision of e-commerce point-of-sale lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.

Katapult Holdings Inc

KPLT is trending due to a merger announcement with The Aarons Company and CCF Holdings, sparking significant community discussion.  While some traders are celebrating quick profits and highlighting the potential for a squeeze, others are analyzing the implications of Katapult stockholders owning only 6% of the combined company. This deal creates an omnichannel financial solutions platform aimed at non-prime consumers.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as investors react to news of the CEO's upcoming departure and anticipate the earnings report. The community is actively discussing potential upgrades, buyback programs, and the impact of international sales, while also considering whether a change in leadership can revitalize the brand's performance. Some traders are noting positive chart momentum, while others remain skeptical about long-term growth.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending amid discussions of its pipeline potential in treating cancers, particularly prostate cancer, and community excitement around positive trial data. Investors are speculating on potential buyouts and partnerships, while also noting the stock's undervaluation and high short interest, which could lead to a short squeeze. The company's upcoming R&D day is also generating buzz.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gossamer Bio (NASDAQ:GOSS) Hits New 1-Year High - Time to Buy?

Gossamer Bio (NASDAQ:GOSS) Hits New 12-Month High - What's Next...

Gossamer Bio (NASDAQ:GOSS) Hits New 52-Week High - Should You Buy?

Gossamer Bio (NASDAQ:GOSS) Hits New 52-Week High - Still a Buy...

Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.9% - Still a Buy?

Gossamer Bio (NASDAQ:GOSS) Shares Up 5.9% - Here's Why...

Gossamer Bio, Inc. (NASDAQ:GOSS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Gossamer Bio, Inc. (NASDAQ:GOSS - Get Free Report) have received a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the company, MarketBeat reports...

Gossamer Bio (NASDAQ:GOSS) Shares Up 7.4% - Should You Buy?

Gossamer Bio (NASDAQ:GOSS) Trading 7.4% Higher - Here's Why...

Acadian Asset Management LLC Raises Position in Gossamer Bio, Inc. $GOSS

Acadian Asset Management LLC lifted its position in Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 12.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with...

FY2025 Earnings Forecast for Gossamer Bio Issued By Wedbush

Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) - Stock analysts at Wedbush lowered their FY2025 EPS estimates for shares of Gossamer Bio in a report issued on Thursday, November 6th. Wedbush analyst...

Gossamer Bio to Participate in Upcoming Investor Conferences

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial...

Gossamer Bio (NASDAQ:GOSS) Issues Earnings Results, Misses Expectations By $0.02 EPS

Gossamer Bio (NASDAQ:GOSS - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.19) by...

Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates

Gossamer Bio (GOSS) delivered earnings and revenue surprises of -10.53% and +118.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.

Gossamer Bio Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

GOSS
Gossamer Bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GOSS News

GOSSGossamer Bio Inc